home / stock / adpt / adpt quote
Last: | $3.59 |
---|---|
Change Percent: | 0.55% |
Open: | $3.59 |
Close: | $3.59 |
High: | $3.6291 |
Low: | $3.49 |
Volume: | 961,519 |
Last Trade Date Time: | 05/20/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.59 | $3.59 | $3.59 | $3.6291 | $3.49 | 961,519 | 05-20-2024 |
$3.61 | $3.75 | $3.61 | $3.76 | $3.57 | 1,573,104 | 05-17-2024 |
$3.72 | $3.86 | $3.72 | $3.95 | $3.685 | 1,834,158 | 05-16-2024 |
$3.9 | $4.07 | $3.9 | $4.11 | $3.86 | 1,451,078 | 05-15-2024 |
$3.96 | $3.86 | $3.96 | $4.2 | $3.86 | 2,241,300 | 05-14-2024 |
$3.8 | $3.51 | $3.8 | $3.93 | $3.5 | 2,056,611 | 05-13-2024 |
$3.5 | $3.57 | $3.5 | $3.64 | $3.455 | 1,221,825 | 05-10-2024 |
$3.56 | $3.2 | $3.56 | $3.575 | $3.11 | 1,417,130 | 05-09-2024 |
$3.18 | $3.36 | $3.18 | $3.765 | $3.1218 | 2,146,065 | 05-08-2024 |
$3.11 | $3.28 | $3.11 | $3.28 | $3.1 | 1,110,526 | 05-07-2024 |
$3.22 | $3.04 | $3.22 | $3.23 | $3.01 | 1,473,394 | 05-06-2024 |
$3.01 | $2.99 | $3.01 | $3.14 | $2.95 | 1,094,025 | 05-03-2024 |
$2.93 | $2.87 | $2.93 | $2.94 | $2.74 | 1,114,450 | 05-02-2024 |
$2.79 | $2.63 | $2.79 | $2.94 | $2.56 | 1,608,528 | 05-01-2024 |
$2.62 | $2.73 | $2.62 | $2.8 | $2.615 | 1,508,837 | 04-30-2024 |
$2.75 | $2.62 | $2.75 | $2.8 | $2.62 | 1,638,992 | 04-29-2024 |
$2.6 | $2.61 | $2.6 | $2.725 | $2.555 | 1,074,607 | 04-26-2024 |
$2.61 | $2.54 | $2.61 | $2.64 | $2.48 | 1,839,185 | 04-25-2024 |
$2.6 | $2.54 | $2.6 | $2.6675 | $2.51 | 1,971,786 | 04-24-2024 |
$2.58 | $2.5 | $2.58 | $2.73 | $2.45 | 1,517,083 | 04-23-2024 |
News, Short Squeeze, Breakout and More Instantly...
Adaptive Biotechnologies Corporation Company Name:
ADPT Stock Symbol:
NASDAQ Market:
Adaptive Biotechnologies Corporation Website:
2024-05-08 18:43:24 ET Adaptive Biotechnologies (NASDAQ: ADPT) , a company that, in its own words, "aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease," was the cure for the stock market blahs on Wednesday. The commercia...
SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease...
Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...